31 completed. 31 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 31 | Completed 31 |
Follow Bleomycin: new trials by email Literature Review of Bleomycin trials Research Report on Bleomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) Pembrolizumab, Doxorubicin, Vinblastine - Classical Hodgkin Lymphoma | Phase 2 | Completed | Merck Sharp & Dohme LLC | 146 | 2021-10-07 | 2025-06-06 |
| Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts Bleomycin Injection, Cryotherapy - Cutaneous Warts | Phase 2 | Completed | Jinnah Postgraduate Medical Centre | 154 | 2021-01-01 | 2021-08-26 |
| Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD brentuximab vedotin, Cyclophosphamide, Adriamycin - Hodgkin Lymphoma | Phase 2 | Completed | The Lymphoma Academic Research Organisation | 40 | 2015-04-01 | 2021-07-26 |
| Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. Doxorubicin, Bleomycin, Vinblastine - Hodgkin Lymphoma | Phase 2 | Completed | The Lymphoma Academic Research Organisation | 170 | 2015-03-01 | 2022-08-19 |
| Calcium Electroporation for Treatment of Cutaneous Metastases Calcium electroporation, Electrochemotherapy with bleomycin - Cutaneous Metastases | Phase 2 | Completed | Herlev Hospital | 7 | 2013-09-01 | 2019-11-05 |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A ABVE-PC, DECA - Hodgkin Disease | Phase 2 | Completed | Baylor College of Medicine | 40 | 2012-12-19 | 2024-01-12 |
| Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma Bleomycin Sulfate, Doxorubicin Hydrochloride, Procarbazine Hydrochloride - Lymphoma | Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 164 | 2010-05-01 | 2021-06-14 |
| S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma bleomycin sulfate, filgrastim, ABVD regimen - Lymphoma, Nonneoplastic Condition | Phase 2 | Completed | SWOG Cancer Research Network | 371 | 2009-07-01 | 2022-08-18 |
| Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma Bleomycin, Dacarbazine, Doxorubicin Hydrochloride - Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 | Phase 2 | Completed | M.D. Anderson Cancer Center | 58 | 2008-03-19 | 2020-02-28 |
| Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma Adriamycin®, Vinblastine, Nitrogen Mustard - Hodgkin's Lymphoma | Phase 2 | Completed | St. Jude Children's Research Hospital | 81 | 2006-07-20 | 2023-09-22 |
| Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma Bleomycin, Rituximab, Dacarbazine - Lymphoma | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 51 | 2006-05-01 | 2018-08-27 |
| Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma Velcade, Doxorubicin, Prednisone - Peripheral T-cell Lymphoma | Phase 2 | Completed | Lymphoma Study Association | 60 | 2006-01-08 | 2018-08-23 |
| Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors bleomycin sulfate, carboplatin, cisplatin - Extragonadal Germ Cell Tumor, Teratoma | Phase 2 | Completed | Medical Research Council | 88 | 2005-06-01 | 2013-08-26 |
| Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors bleomycin sulfate, pegfilgrastim, cisplatin - Extragonadal Germ Cell Tumor, Teratoma | Phase 2 | Completed | Cambridge University Hospitals NHS Foundation Trust | 20 | 2004-08-01 | 2013-08-07 |
| Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma Cyclophosphamide, Adramycin, Procarbacine - Hodgkin´s Lymphoma | Phase 2 | Completed | University of Cologne | 65 | 2004-01-01 | 2011-07-29 |
| A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years bleomycin sulfate, cyclophosphamide, etoposide - Lymphoma | Phase 2 | Completed | Newcastle-upon-Tyne Hospitals NHS Trust | 175 | 2004-01-01 | 2017-03-30 |
| Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma Vincristine, Cyclophosphamide, Doxorubicin - Lymphoma, Hodgkin Disease, Lymphoma | Phase 2 | Completed | Stanford University | 76 | 2001-06-01 | 2018-07-24 |
| Rituximab and ABVD for Hodgkin's Patients Rituximab, Adriamycin, Bleomycin - Lymphoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 85 | 2001-03-01 | 2013-07-09 |
| Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors bleomycin sulfate, amifostine trihydrate, cisplatin - Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ | Phase 2 | Completed | Children's Oncology Group | 27 | 2000-04-01 | 2013-07-04 |
| Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease bleomycin sulfate, filgrastim, ABVD regimen - Lymphoma | Phase 2 | Completed | Children's Oncology Group | 99 | 1999-10-01 | 2014-02-26 |
Showing 20 of 31. Sign in to see all of them.
Hodgkin Disease (16) · Lymphoma (14) · Testicular Neoplasms (4) · HIV Infections (3) · Teratoma (3) · Acquired Immunodeficiency Syndrome (2) · Burkitt Lymphoma (2) · Carcinoma, Embryonal (2) · Endodermal Sinus Tumor (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2) · Lymphoma, Non-Hodgkin (2) · Testicular Germ Cell Tumor (2) · AIDS-Related Complex (1)
M.D. Anderson Cancer Center (4) · SWOG Cancer Research Network (3) · Stanford University (3) · Children's Oncology Group (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · The Lymphoma Academic Research Organisation (2) · Alliance for Clinical Trials in Oncology (1) · Baylor College of Medicine (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Case Comprehensive Cancer Center (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Herlev Hospital (1) · Jinnah Postgraduate Medical Centre (1) · Lymphoma Study Association (1) · Medical Research Council (1)
United States (21) · France (4) · Australia (3) · Canada (3) · United Kingdom (3) · Belgium (2) · Denmark (2) · Germany (2) · Italy (2) · Netherlands (2) · Chile (1) · Croatia (1) · Israel (1) · Pakistan (1) · Poland (1)
Anas Younes, MD (2) · Lode J. Swinnen, MD (2) · Sandra J. Horning, MD (2) · Alain Delmer, MD (1) · Andrea Necchi, MD (1) · Andreas Josting, Dr. (1) · Bertrand Coiffier, MD (1) · Carl E. Allen, MD, PhD (1) · David J. Straus, MD (1) · Helen H. Lucraft, MD (1) · Hun Lee (1) · Jamie Flerlage, MD (1) · Julie Gehl (1) · Kara Kelly, MD (1) · Katrina M. Wood, MD (1)
PMID 40135712, PMID 14508361, PMID 15999362, PMID 18645482, PMID 20551376, PMID 21079154, PMID 22371887, PMID 25001888, PMID 25344361, PMID 28816072, PMID 30049811, PMID 30723079, PMID 31331918, PMID 35867960, PMID 39620432, PMID 7537796, PMID 8836420
U10CA032102 (3), P30CA016672 (2), P30CA006973 (1), P30CA043703 (1), U10CA180821 (1)